Author

C. DiNardo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1

Frequent Co-Authors

E. Jabbour· 2 shared F. Ravandi· 2 shared G. Garcia-Manero· 2 shared H. Kantarjian· 2 shared K. Patel· 2 shared K. Takahashi· 2 shared M. Konopleva· 2 shared A. Futreal· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. Jabbour

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genetics of Latin American Diversity (GLAD) Project: insights into population genetics and association studies in recently admixed groups in the Americas

V. Borda, D. P. Loesch, B. Guo, R. Laboulaye, D. Veliz-Otani, J. N. French-Kwawu, T. Peixoto Leal, S. M. Gogarten, S. Ikpe, M. H. Gouveia, M. Mendes, G. R. Abecasis, I. Alvim, C. E. Arboleda-Bustos, G. Arboleda, , Kooper

The GLAD Project compiles genome-wide data from 54,077 Latin Americans and develops tools for ancestry matching and statistical software evaluation in admixed populations.

bioRxiv · Jan 7, 2023 · PreprintGenetics

Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

F. Wang, K. Morita, C. DiNardo, K. Furudate, T. Tanaka, Y. Yan, K. Patel, K. MacBeth, B. Wu, G. Liu, M. Frattini, J. Matthews, L. Little, C. Gumbs, X. Song, , K. Takahashi

The paper identifies leukemia stemness and co-occurring mutations as drivers of resistance to IDH inhibitors in AML through genomic analyses of treated patients.

bioRxiv · Oct 27, 2020Cancer Biology

Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia

G. Montalban-Bravo, R. Kanagal-Shamanna, K. Sasaki, L. Masarova, K. Naqvi, E. Jabbour, C. DiNardo, K. Takahashi, M. Konopleva, N. Pemmaraju, T. M. Kadia, F. Ravandi, N. G. Daver, G. M. Borthakur, Z. E. Estrov, , G. Garcia-Manero

This study examines clinicopathologic features and treatment outcomes in 65 patients with atypical chronic myeloid leukemia, identifying key mutations and predictors of survival.

bioRxiv · Sep 10, 2020Cancer Biology

Polygenic mutations model the pleiotropic disease of Fanconi Anemia

K. Schlacher, K.-H. Tomaszowski, S. Roy, C. Keshvani, M. Ott, C. DiNardo, D. Schindler

This study shows that mutations in two FANC genes in mice model the severity and heterogeneity of Fanconi Anemia, revealing functional synergism of polygenic mutations.

bioRxiv · Sep 1, 2020 · PreprintCancer Biology